This month we are reading about:

• non-DiGA pathways for digital app reimbursement in Germany.
• need for change in reimbursement and patient value definitions in an ever more personalised care environment
• gene therapies and microbiome medicines entering the market right now
• evidence requirements for faster HTA
  

Have a good read!